OYIDIE IGBOKIDI

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology HOT SPRINGS, AR NPI 1104896497

General Payments — all program years on this page

$4,074.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 199
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $371.49 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $371.4918

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $780.1554
2019 $808.5265
2020 $1,195.1914
2021 $233.637
2022 $375.8521
2023 $309.6920
2024 $371.4918

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080677292 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $4.21 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086846799 Novartis Pharmaceuticals Corporation $15.40 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086846803 Novartis Pharmaceuticals Corporation $12.01 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086846805 Novartis Pharmaceuticals Corporation $2.07 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086846817 Novartis Pharmaceuticals Corporation $18.74 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086846819 Novartis Pharmaceuticals Corporation $32.67 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086846825 Novartis Pharmaceuticals Corporation $14.49 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086846853 Novartis Pharmaceuticals Corporation $17.55 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086846859 Novartis Pharmaceuticals Corporation $29.08 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101460261 E.R. Squibb & Sons, L.L.C. $16.33 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101460280 E.R. Squibb & Sons, L.L.C. $19.97 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117067032 Medtronic, Inc. $16.88 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118286040 Baxter Healthcare $22.13 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118286044 Baxter Healthcare $22.14 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142232004 ABIOMED $81.64 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146859728 Philips North America LLC $13.91 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146859730 Philips North America LLC $14.68 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154056016 iRhythm Technologies, Inc. $17.59 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.